Gynae-oncology

Gynaecological Oncology

The Group's Co-ordinating Editor for gynaecological oncology is Jo Morrison, whose responsibilities are to ensure that each stage of the process (the title, the protocol, the review and subsequent updates) meet the rigorous Methodological Expectations for Cochrane Intervention Reviews (MECIR) standards and are reviewed by a variety of specialists including consumer advocates. Jo is a Consultant Gynaecological Oncologist at the Musgrove Park Hospital in Taunton, with a special interest in colposcopy and gynaecology enhanced recovery programmes. Jo also represents the South West of England on the board of the British Gynaecological Cancer Society (BGCS).

We have 3 titles that require new author teams, these are:

  • Tamoxifen for relapse of ovarian cancer
  • Perioperative enhanced recovery programmes for gynaecological cancer patients
  • Impact of epithelial ovarian cancer screening on patient-relevant outcomes in average-risk postmenopausal women

Please contact us if you are interested in updating any of the above ruh-tr.gnoc-cochrane@nhs.net

The gynaecological oncology aspect of CGNOC covers systematic reviews in the following topic areas:
• Uterine cervix
• Body of uterus
• Vagina/fallopian tube
• Ovary
• Chorioncarcinoma
• Vulva
• Prevention
• Screening for pre-malignant changes
• Strategies for early detection of cancer
• Treatment of early disease
• Treatment of late disease

The CGNOC also provide Cochrane with an editorial base for cancer reviews outside the scope of any current Cochrane Group (CG).  Topic areas include;

• Soft tissue sarcomas
• Aspects of care of cancer patients not relating to cancer of a specific site e.g. infections in people with cancer
• Palliative and supportive care (in conjunction with the Pain, Palliative and Supportive Care Group)
• Psychosocial interventions and outcomes, including rehabilitation